185
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Rapid Detection of Adulteration in Boswellia Extracts with Citric Acid by UPLC–HRMS and 1H NMR

, , , , &

References

  • Abdel-Tawab M, Werz O, Schubert-Zsilavecz M. 2011. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet. 50(6):349–369. doi:10.2165/11586800-000000000-00000.
  • Badria FA, Mikhaeil BR, Maatooq GT, Amer MMA. 2003. Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Zeitschrift Für Naturforschung C. 58(7–8):505–516. doi:10.1515/znc-2003-7-811.
  • Bampidis V, Azimonti G, Bastos MdL, Christensen H, Fašmon Durjava M, Kouba M, López‐Alonso M, López Puente S, Marcon F, Mayo B, et al. 2022. Safety and efficacy of a feed additive consisting of an extract of olibanum from Boswellia serrata Roxb. ex Colebr. for use in dogs and horses (FEFANA asbl). EFSA J. 20(3):e07158. doi:10.2903/j.efsa.2022.7158.
  • Basch E, Boon H, Davies-Heerema T, Foppo I, Hashmi S, Hasskarl J, Sollars D, Ulbricht C. 2004. Boswellia: an evidence-based systematic review by the Natural Standard Research Collaboration. J Herb Pharmacother. 4(3):63–83. doi:10.1080/J157v04n03_06.
  • Belsner K, Büchele B, Werz U, Syrovets T, Simmet T. 2003. Structural analysis of pentacyclic triterpenes from the gum resin of Boswellia serrata by NMR spectroscopy. Magn Reson Chem. 41(2):115–122. doi:10.1002/mrc.1138.
  • Binns CW, Lee MK, Lee AH. 2018. Problems and prospects: public health regulation of dietary supplements. Annu Rev Public Health. 39(1):403–420. doi:10.1146/annurev-publhealth-040617-013638.
  • Bongers F, Groenendijk P, Bekele T, Birhane E, Damtew A, Decuyper M, Eshete A, Gezahgne A, Girma A, Khamis MA, et al. 2019. Frankincense in peril. Nat Sustain. 2(7):602–610. doi:10.1038/s41893-019-0322-2.
  • Casetext. 2019. Jiaherb, Inc., v. MTC Industries, Inc. (United States District Court of New Jersey; Civil No. 18-15532 (KSH) (CLW); September 30, 2019). https://Casetext.Com/Case/Jiaherb-Inc-v-Mtc-Indus-Inc/.
  • Csuk R, Barthel-Niesen A, Ströhl D, Kluge R, Wagner C, Al-Harrasi A. 2015. Oxidative and reductive transformations of 11-keto-β-boswellic acid. Tetrahedron. 71(13):2025–2034. doi:10.1016/j.tet.2015.01.062.
  • Czepielewska E, Makarewicz-Wujec M, Różewski F, Wojtasik E, Kozłowska-Wojciechowska M. 2018. Drug adulteration of food supplements: a threat to public health in the European Union? Regul Toxicol Pharmacol. 97:98–102. doi:10.1016/j.yrtph.2018.06.014.
  • DeCarlo A, Ali S, Ceroni M. 2020. Ecological and economic sustainability of non-timber forest products in post-conflict recovery: a case study of the frankincense (Boswellia spp.) resin harvesting in Somaliland (Somalia). Sustainability. 12(9):3578. doi:10.3390/su12093578.
  • EDQM. 2023. Indian frankincense (Olibanum indicum). In: European Pharmacopoeia (11.0). EDQM Council of Europe; p. 1562–1563.
  • Gafner S, Blumenthal M, Foster S, Cardellina JH, Khan IA, Upton R. 2023. Botanical ingredient forensics: detection of attempts to deceive commonly used analytical methods for authenticating herbal dietary and food ingredients and supplements. J Nat Prod. 86(2):460–472. doi:10.1021/acs.jnatprod.2c00929.
  • Ganga RG, Rama RG, Venkata SG, Trimurtulu G, Sridhar P. 2004. Process for producing a fraction enriched up to 100% of 3-o-acetly-11-keto-beta boswellic acid from an extract containing a mixture of boswellic acids. United States patent US 2004/0073060 A1.
  • Giraudeau P. 2023. Quantitative NMR spectroscopy of complex mixtures. Chem Commun. 59(44):6627–6642. doi:10.1039/D3CC01455J.
  • GlobeNewsWire. 2020. Vitamins and supplements market to reach USD 185.16 billion by 2027; addition of natural herbs & botanicals to boost growth, says Fortune Business Insights™. https://www.globenewswire.com/News-Release/2020/11/01/2118082/0/En/Vitamins-and-Supplements-Market-to-Reach-USD-185-16-Billion-by-2027-Addition-of-Natural-Herbs-Botanicals-to-Boost-Growth-Says-Fortune-Business-Insights.Html.
  • Gokaraju GR, Gokaraju RR, Gokaraju VKRR, Golakoti T, Bhupathiraju K, Alluri VKR. 2010. Synergistic anti-inflammatory compositions comprising Boswellia serrata extracts. Patent: WO/2010/029578. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2010029578.
  • Gupta R, Gupta V, Gupta V, Atal C. 1984. Non aqueous method for estimation of total triterpene acids in salai guggal and its different forms. Indian Drugs. 21:523–525.
  • Iucnredlist. 2023. The IUCN red list of threatened species. https://www.Iucnredlist.Org/Search?query=boswellia&searchType=species. https://www.iucnredlist.org/search?query=boswellia&searchType=species.
  • Jairath V, Feagan BG. 2020. Global burden of inflammatory bowel disease. Lancet Gastroenterol Hepatol. 5(1):2–3. doi:10.1016/S2468-1253(19)30358-9.
  • Katragunta K, Siva B, Kondepudi N, Vadaparthi PRR, Rama Rao N, Tiwari AK, Suresh Babu K. 2019. Estimation of boswellic acids in herbal formulations containing Boswellia serrata extract and comprehensive characterization of secondary metabolites using UPLC-Q-Tof-MSe. J Pharm Anal. 9(6):414–422. doi:10.1016/j.jpha.2019.09.007.
  • Kimmatkar N, Thawani V, Hingorani L, Khiyani R. 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee – a randomized double blind placebo controlled trial. Phytomedicine. 10(1):3–7. doi:10.1078/094471103321648593.
  • Kulkarni PD, Damle ND, Singh S, Yadav KS, Ghante MR, Bhaskar VH, Hingorani L, Gota VS. 2020. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee. Drug Metab Drug Interact. 35(2):20200104. doi:10.1515/dmpt-2020-0104.
  • Lakshmi T, Rajendran R. 2013. Quantitative estimation of boswellic acids and gymnemic acids in Boswellia serrata and Gymnema sylvestre extract. Int J ChemTech Res. 5(6):2913–2916.
  • Leifer VP, Katz JN, Losina E. 2022. The burden of OA-health services and economics. Osteoarthr Cartil. 30(1):10–16. doi:10.1016/j.joca.2021.05.007.
  • Madisch A, Miehlke S, Eichele O, Mrwa J, Bethke B, Kuhlisch E, Bästlein E, Wilhelms G, Morgner A, Wigginghaus B, et al. 2007. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis. 22(12):1445–1451. doi:10.1007/s00384-007-0364-1.
  • Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. 2019. A pilot, randomized, double‐blind, placebo‐controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res. 33(5):1457–1468. doi:10.1002/ptr.6338.
  • Miscioscia E, Shmalberg J, Scott KC. 2019. Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata supplements administered to dogs. BMC Vet Res. 15(1):270. doi:10.1186/s12917-019-2021-7.
  • Moussaieff A, Mechoulam R. 2009. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol. 61(10):1281–1293. doi:10.1211/jpp/61.10.0003.
  • Orhan N, Temiz B, Ağalar HG, İşcan G. 2022. Boswellia serrata oleogum resins and extract laboratory guidance document (Botanical Adulterants Prevention Program). ABC, AHP, NCNPR. https://www.herbalgram.org/resources/botanical-adulterants-prevention-program/laboratory-guidance-documents/boswellia-serrata-laboratory-guidance-document-august-2022/.
  • Poerwono H, Higashiyama K, Kubo H, Poernomo AT, Suharjono Sudiana IK, Indrayanto G, Brittain HG. 2001. Citric acid. In: Brittain HG, editor. Analytical profiles of drug substances and excipients. Vol. 28. Academic Press; p. 1–76. doi:10.1016/S1075-6280(01)28002-1.
  • Rashan L, Hasson SSAA, Simmet T, Al Balushi MSA, Al Jabri AAH. 2020. Boswellic acid extraction. Patent: EP 3 7 33 195 A1.
  • Rebiai A, Seghir BB, Hemmami H, Zeghoud S, Amor IB, Kouadri I, Messaoudi M, Pasdaran A, Caruso G, Sharma S, et al. 2022. Quality assessment of medicinal plants via chemometric exploration of quantitative NMR data: a review. Compounds. 2(2):163–181. doi:10.3390/compounds2020012.
  • Schmiech M, Lang SJ, Werner K, Rashan LJ, Syrovets T, Simmet T. 2019. Comparative analysis of pentacyclic triterpenic acid compositions in oleogum resins of different Boswellia species and their in vitro cytotoxicity against treatment-resistant human breast cancer cells. Molecules. 24(11):2153. doi:10.3390/molecules24112153.
  • Seligson AL, Terry RC, Alexander D, Sovak M. 2003. Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-bosellic acid (“AKBA”). Industrial manufacture and their uses. World Intellectual Property Organization Patent WO 03/077860 A2.
  • Sengupta K, Alluri KV, Satish A, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP. 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin(R) for treatment of osteoarthritis of the knee. Arthritis Res Ther. 10(4):R85. doi:10.1186/ar2461.
  • Sharma N, Bhardwaj V, Singh S, Ali SA, Gupta DK, Paul S, Satti NK, Chandra S, Verma MK. 2016. Simultaneous quantification of triterpenic acids by high performance liquid chromatography method in the extracts of gum resin of Boswellia serrata obtained by different extraction techniques. Chem Cent J. 10(1):49. doi:10.1186/s13065-016-0194-8.
  • Sharma S, Thawani V, Hingorani L, Shrivastava M, Bhate VR, Khiyani R. 2004. Pharmacokinetic study of 11-keto β-boswellic acid. Phytomedicine. 11(2–3):255–260. doi:10.1078/0944-7113-00290.
  • United States Pharmacopeia. 2023a. Dietary supplement monographs, Boswellia serrata. Rockville, MD: The United States Pharmacopeia.
  • United States Pharmacopeia. 2023b. Dietary supplement monographs, Boswellia serrata extract. Rockville, MD: United States Pharmacopeia.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.